Evaluation of the effect of midazolam in controlling uncomplicated hypertension in patients presenting to the emergency department

Evaluation of the effect of midazolam in controlling uncomplicated hypertension in patients presenting to the emergency department: a randomized, double-blind clinical trial study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20260306068968N1

Enrollment

142

Registered

2026-04-25

Start date

2026-04-21

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. ???????

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: hypertension crisis contious

Exclusion criteria

Exclusion criteria: End organ damage Pregnant women

Design outcomes

Primary

Measure	Time frame
Blood pressure control. Timepoint: At baseline, and at 15 , 30 , 45 , and 60 minutes after initation of treatment. Method of measurement: Blood pressure monitor.	—

Secondary

Measure	Time frame
Patient satisfaction with the treatment. Timepoint: 15 - 30 - 45 - 60 minutes. Method of measurement: digital wristwatch for time measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactasghar jafari rouhi

Tabriz University of Medical Sciences

sadeghifatemeh0617@gmail.com+98 41 3335 2078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026